A new study, published in the Annals of Internal Medicine, examined the role of fecal microbiota transplantation for Clostridium difficile infection.
Here are four things to know:
1. Researchers conducted two randomized, controlled trials in which 28 case-series studies and five case reports were included.
2. Fecal microbiota transplantation was successful in 85 percent of recurrent CDI studies.
3. Fecal microbiota transplantation may have a substantial effect with few short-term adverse events for recurrent CDI, study authors concluded.
4. However, evidence is insufficient on fecal microbiota transplantation for refractory or initial CDI treatment, they note.